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INTRODUCTION: Primary cutaneous extraskeletal Ewing’s sarcomas (ESs) are extremely rare tumors, lim-
ited to the skin and generally appear as a single small lesion, circumscribed mid-to-deep dermis or
involving subcutis. Due to their rarity and morphological similarity to other cutaneous tumors, ESs are
subject to being clinically and pathologically subdiagnosed.
PRESENTATIONOFCASE:A37-year-oldmanpresenteda large rapidly growingmassof theﬁrst toemeasur-
ing 9.5×8 cm with no radiological evidence of bone involvement. The patient underwent wide surgical
tumor resection; histological, immunohistochemical and molecular evaluation conﬁrmed the diagnosis
of ESs. Postoperative examinations revealed no metastasis and after 11 months follow-up no recurrences
were detected.
DISCUSSION:Current literature reportsonlya few isolatedcasesor small series. ESsaregenerallydescribed
as small masses with a favorable clinical behavior. Despite lower extremity is a relatively frequent site,
only rare and small ESs of the foot have been reported. To our knowledge the present case is the largest
ES of the foot. Despite its large size, the patient did not report any metastases conﬁrming the hypothesis
of treating superﬁcial ES with surgery alone, thus avoiding adjuvant radiotherapy and/or chemotherapy
and their related side-effects.
CONCLUSION: ESs still remain exceedingly rare tumors and they could not be taken in consideration into
differential diagnosis. This case represents a peculiar example of large ES in an uncommon site as the
foot successfully treated with surgery alone, and may serve as an alert for those physicians who approach
such rapidly growing superﬁcial lesions.
© 2015 The Authors. Published by Elsevier Ltd. on behalf of Surgical Associates Ltd. This is an open
he CCaccess article under t
. Introduction
Extraskeletal Ewing’s sarcoma family of tumors (ESFT)most fre-
uently occur in the deep soft tissues of children and young adults,
uch as paraspinal muscles, chest wall, and the lower extremities
1,2]. Nevertheless, it occasionally presents in a superﬁcial location
ither as a primary tumor or a metastasis from osseous or deep-
eated extraskeletal ESFT [1]. Those superﬁcially located lesions,
he so-called primary cutaneous extraskeletal Ewing’s sarcomas,
re exceedingly rare and they are limited to the skin and generally
resent as a single small lesion, circumscribed mid-to-deep der-
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mis or involving superﬁcial subcutis [2]. They were ﬁrst described
by Angerwall and Enzinger in 1975 [3]; since then the literature
reports only a few isolated cases or small series as recently inves-
tigated by Delaplace et al. with a systematic review [4].
Clinically, morphologically and genetically, extraskeletal
Ewing’s sarcoma (ESs) and primitive neuroectodermal tumors
(PNETs) share a lot of features, supporting the hypothesis that
these two neoplasms are histogenetically related and then are
widely considered as part of the same family of tumors [2].
Their clinical presentation usually provides a superﬁcial single
mass of 2–3 cm, soft, mobile and sometime painful with an average
evolution time of 5months [5]. A statistically female predominance
with a median age at diagnosis of 17 years has been described
[4]. The diagnosis may require several ancillary techniques such
as aspiration cytology, histochemical stains, immunohistochem-
istry, electron microscopy, cytogenetics and molecular genetics of
traslocations. The histological aspect of small round cells, immuno-
iates Ltd. This is an open access article under the CC BY-NC-ND license (http://
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Fig. 2. Low power view (H&E, 10× magniﬁcation) of superﬁcial Ewing’s sarcoma.
Fig. 3. High power view (H&E, 20× magniﬁcation) of extraskeletal Ewing’s sarcoma
characterized by small round cell tumor of striking uniformity.ig. 1. Large polypoid mass of the ﬁrst toe of the left foot in a 37-year-old man
size, 9.5×8 cm). The surface shows irregular edges, necrotic and bleeding areas
ith several ulcerations.
istochemically positive for CD99 in characteristic membrane
attern and the speciﬁc chromosomal translocation involving gene
WSR1 in chromosome 22q12 are essential criteria for cutaneous
Ss diagnosis [5,6].
Owing to the rarity of these tumors and the relative non-
peciﬁcity of their histology and immunoproﬁle, the diagnosis
f superﬁcial ES is difﬁcult and numerous differential diagnoses
ust be considered such as Merkel cell carcinoma, cutaneous lym-
homas, clear cell sarcoma, malignant primitive neuroectodermal
umor, small cell carcinoma, rhabdomyosarcoma, malignant rhab-
oid tumor and poorly differentiated adnexal tumors [1,5,7]. They
isplayed a generally favorable clinical behavior, unlike its deep
ounterpart, with a 10-year probability of survival rate of 91%.
his is probably attributable to their small size and possibly early
etection and complete surgical removal, due to their superﬁcial
ocation, preventing metastatic spread in most patients [4].
The principles of treatment are currently similar to Ewing
arcoma of the bone, including wide surgical resection, being asso-
iated or not with chemotherapy and/or radiotherapy, depending
n its size and location, even if a deﬁnitive conclusion on the most
orrect treatmentmodalities has not yet been elucidated due to the
xtreme rarity of these tumors [4,5].
. Case presentation
We described a case of a 37-year-old Caucasian man with a
arge rapidly growing (3 months’ duration) mass of the ﬁrst toe
f the left foot. He denied any history of recent trauma or infec-
ionsduring themedical history taking; nevertheless the lesionwas
nitially diagnosed and treated as a viral wart by the dermatolo-
ist without resolution. Physical examination revealed a 9.5×8 cm
olypoid, necrotic mass of the ﬁrst toe, with irregular edges, ulcer-
tion and bleeding (Fig. 1). He reported ambulating limitations due
o pain and bulky of the tumor. Radiological examination of the foot
id not reveal any bone lesion. No regional lymph node involve-
ent was clinically detectable and ultrasonography of the inguinal
egion did not detect any abnormalities. The ﬁndings of a blood test
ere within normal limits.
The patient underwent to wide surgical resection of the lesion
ith a 1.5-cm margin; intraoperative sections were forwarded to
athology and typical signs of immature neoplasm were observed.
urther excision with ﬁrst toe amputation (up to the base of prox-
mal phalanx) was thus necessary to obtain free surgical margins.
he post-excisional defect was closed directly without wound
ension. As we preserved the weight-bearing area over the ﬁrst
etatarsal, after surgery he was able to walk using normal shoes.
istological examination revealed a small round blue cell tumor
ccupying the dermis and subcutis and composed of cohesive
heets and trabeculae of uniform, small to medium round cells
ontaining hypercromatic nuclei with small nucleoli and scanty
ale cytoplasm with indistinct cytoplasmic borders (Figs. 2 and 3).
here was prominent mitotic activity (30–35 mitoses/10HPF) and
itotic index, evaluated with Ki67 was about 80%; apoptotic cells
ere numerous. Vague rosettiformpatternwas focally present. The
umor had a lobulated growth pattern separated by ﬁbrovascu-Fig. 4. Strong immunoreactivity for CD99 in a characteristic membranous pattern.
lar septa and contained extensive necrotic and hemorragic areas.
The overlying epidermis was widely ulcerated and the deep mar-
gins were inﬁltrative without any bone involvement. The tumor
showed only focal cytoplasmic globular periodic acid Shiff (PAS)
and was immunohistochemically positive for CD99 in a char-
acteristic membrane pattern (Fig. 4). The differential diagnosis
included other small round cell tumors present in the skin such
as rhabdomyosarcoma, melanoma, carcinoma including Merkel
cell carcinoma, poorly differentiated synovial sarcoma and lym-
phoma; the distinction was possible by absence of staining for
speciﬁc immunohistochemicalmarkers suchasactin, desmin, S100,
HMB45, CK20, synaptophisin, chromogranin, TLE-1, Tdt, CD20 and
CD3. The molecular results shows t(11;22 translocation) involving
gene EWRS1.
A postoperative whole-body computed tomography (CT) scan
and positron emission tomography scan using ﬂuorodeoxyglucose
(18F-FDG-PET) revealed no metastases. The patient did not receive
any adjuvant chemotherapy or radiotherapy according to oncolo-
gist consultation and after 11 months of follow-up period there is
no evidence of recurrence (Fig. 5). After treatment he was followed
every three months through clinical examination, while magnetic
resonance imaging (MRI) was performed every 6 months during
the ﬁrst year.
3. Discussion
ESFT are usually found in bone and deep soft tissue of young
patients and they could be subdivided into osseous or extra osseous
ESFT. Althoughextra osseous ESFTusually occur in thedeep soft tis-
sues, extremely rare superﬁcial/dermal/cutaneous cases have been
reported [1]. Due to its rarity and morphological similarity to other
cutaneous tumors, cutaneous ESs are subject to being clinically and
pathologically subdiagnosed [5]. Since the ﬁrst report of Angerwall
and Enzinger in 1975, only a few isolated cases or small series have
been described in the available literature.
Delaplace et al. recently investigated with a systematic review
that cutaneous ESs have usually a high 10-year probability of
survival (91%) due to their superﬁcial location, thus allowing early
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Table 1
Literature review showing the largest case series or single case report with foot superﬁcial Ewing sarcoma.
Authors Cases Foot lesions Median size Median age Median
follow-up
Median disease
free time
Chow et al. [8] 14 1 (size, 2 cm) 3 cm (range,
1–12 cm)
13.8 years
(range, 7–21)
64,6 months
(range,
17–111)
64,6 months
Terrier-Lacombe et al. [7] 14 1 (size, 1.5 cm) 3 cm (range,
1–5 cm)
30.8 years
(range, 12–77)
44.8 months
(range, 11–84)
43.5 months
(1 case: NA)
Ehrig et al. [10] 13 1 (size, 0.5 cm) 1.3 cm (range,
0.5–2.3 cm)
28.4 years
(range, 2–67)
87,8 months
(range,
18–132)
(2 cases: NA)
86,7 months
(2 cases: NA)
Banerjee et al. [9] 8 None 3.8 cm (range,
1–10 cm)
17.1 years
(range, 9–36)
36 months
(range, 6–96)
(1 case: NA)
36 months
(1 case: NA)
Machado et al. [1] 6 1 (size, 5 cm) 4.3 cm (range,
0.5–8 cm)
44.6 years
(range, 22–76)
81.6 months
(range, 5–216)
(3 cases: NA)
81.6 months
(3 cases: NA)
Hasegawa et al. [11] 5 None 2 cm (range,
0.5–7 cm)
18 years
(range, 8–50)
26.6 months
(range, 11–36)
(2 cases: NA)
26.6 months
(2 cases: NA)
Shingde et al. [12] 7 1 (size, NA) NA 31.3 years
(range, 16–61)
34.7 months
(range, 11–57)
34.7 months
Kourda et al. [13] 1 1 (size, 3.5 cm) -–
NA, not available.
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etection and removal. These tumors are generally single small
asses with a median size of 2.3 cm (range 0.5–12 cm), mainly
ocated on the lower limbs (38%), followed by upper limbs (26%),
ead (20%) and trunk (16%) [4], and only few studies reported
he presence of multiple or large lesions [1,2,8,9]. Furthermore
n accurate analysis of the literature (by using Medline, Scopus
nd PubMed electronic databases) displayed that despite lower
xtremity is a relatively frequent site of cutaneous ESs, only rare
eports of primary superﬁcial ESs of the foot have been reported,
ven in the largest case series. Chow et al. [8] described 14 cases
ith a median size of 3 cm; nevertheless only one patient had a
oot lesion (size, 2 cm). Terrier-Lacombe et al. [7] reported 14 cases
median size, 3 cm) with only one foot ESs (size, 1.5 cm). Ehrig et al.
10] collected 13 cases (median size, 1.5 cm) with only one small
oot lesion (size, 0.5 cm). Banerjee et al. [9] and Hasegawa et al.
11] described 8 cases and 5 cases respectively, without any foot
utaneous ESs. Shingde et al. [12] and Machado et al. [1] reported
cases and 6 cases respectively; every study observed one case of
mall tumor of the foot (size, not available and 5 cm, respectively).
ourda et al. [13] described a single case of cutaneous ES of the
oot with a diameter of 3.5 cm (data summarized in Table 1).
To our knowledge the present case is the largest primary cuta-
eous ES of the foot. Despite its large size, the patient did not
eport any metastases and these ﬁndings support the data already9 years NA NA
described in the literature. Indeed, this superﬁcial ES displays a
low rate of metastatic spread in most patients and the presence
of metastases is really rare [4,5,14].
The patientwas successfully treatedwithwide surgical removal
alone, thus avoiding adjuvant radiotherapy and/or chemotherapy
and their related side-effects, and he is free from disease after
11 months. Despite the short follow-up period, this conﬁrms the
hypothesis of treating primary cutaneous ESs with surgery alone
and the need to reconsider its therapeutic protocol due to the
extremerarityof this tumorand the small numberof available cases
[4,14].
4. Conclusions
Although some cases of primary cutaneous ESs have been
described, they still remain exceedingly rare tumors and they could
not be taken in consideration into differential diagnosis. Despite
their median size is generally small, due to their superﬁcial loca-
tion and earlier detection, some reports of large neoplasm have
been reported. The present case represents a further and peculiar
example of large cutaneous ES in an uncommon site as the foot
and may serve as an alert for those physician who approach such
rapidly growing superﬁcial lesions. A prompt clinical, histologi-
cal, immunohistochemical and cytogenetic diagnosis and a proper
treatment remain fundamental for their correct management.
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